Correction: Striatal Dopamine D2/3 Receptor Availability in Treatment Resistant Depression
Bart P. de Kwaasteniet, Chedwa Pinto, Henricus G. Ruhé, Guido A. van Wingen, Jan Booij, Damiaan Denys
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsTreatment of Major Depression · Functional Brain Connectivity Studies · Neurotransmitter Receptor Influence on Behavior
The third author’s name is incorrect. The correct name is: Henricus G. Ruhé.
The correct citation is: de Kwaasteniet BP, Pinto C, Ruhé HG, van Wingen GA, Booij J, Denys D (2014) Striatal Dopamine D_2/3_ Receptor Availability in Treatment Resistant Depression. PLoS ONE 9(11): e113612. doi:10.1371/journal.pone.0113612.
The correct author contributions are: Conceived and designed the experiments: BDK CP JB HGR. Performed the experiments: BDK CP. Analyzed the data: BDK CP. Contributed reagents/materials/analysis tools: BDK CP JB. Wrote the paper: BDK CP JB HGR GVW DD.
The reference list from the paper itself. Each links out to its DOI / PubMed record.